scispace - formally typeset
R

Rachel Grimley

Researcher at GlaxoSmithKline

Publications -  7
Citations -  467

Rachel Grimley is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Rhodospirillum rubrum & Sirtuin. The author has an hindex of 5, co-authored 7 publications receiving 438 citations.

Papers
More filters
Journal ArticleDOI

Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket

TL;DR: This study confirms the irreversible covalent binding of the inhibitor to the kinase by x-ray crystallography and enzymology while demonstrating potency, selectivity, and prolonged duration of action in in vitro biological assays.
Journal ArticleDOI

Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses.

TL;DR: It is confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this de acetylase activity is unusually low in biochemical assays.
Journal ArticleDOI

Interaction of Nucleotides with the NAD(H)-binding Domain of the Proton-translocating Transhydrogenase of Rhodospirillum rubrum

TL;DR: The difference in the binding affinity between NADH and NAD indicates that there may be an energy requirement for the transfer of reducing equivalents into this site in the complete enzyme under physiological conditions, and suggests that the loop has closed down to within 0.5 nm of the nucleotide.
Journal ArticleDOI

Identification of novel interacting partners of Sirtuin6.

TL;DR: A number of interacting partners are reported which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NFκB biology.